This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Celgene Quanticel Research, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yumin Dai: Innovator in Leukemia Treatment
Introduction
Yumin Dai is a prominent inventor based in Danville, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of leukemia and myelodysplastic syndrome. His innovative approaches have the potential to improve patient outcomes and advance therapeutic options.
Latest Patents
Yumin Dai holds a patent for "Azacitidine in combination with venetoclax, gilteritinib, midostaurin or other compounds for treating leukemia or myelodysplastic syndrome." This patent outlines methods for using 5-azacytidine in combination with additional agents to treat diseases and disorders, including acute myeloid leukemia (AML). His work in this area is crucial for developing more effective treatment regimens.
Career Highlights
Dai is associated with Celgene Quanticel Research, Inc., where he continues to push the boundaries of cancer research. His dedication to innovation in the pharmaceutical industry has positioned him as a key figure in the development of new therapies.
Collaborations
Throughout his career, Yumin Dai has collaborated with notable colleagues, including C L Beach and Shelonitda Rose. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Yumin Dai's contributions to the field of leukemia treatment exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also holds promise for improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile